Apellis Pharmaceuticals
(APLS)
|
13.2 |
$28M |
|
554k |
50.81 |
Aadi Bioscience
(AADI)
|
12.1 |
$26M |
|
1.5M |
16.97 |
Vistagen Therapeutics Com New
|
6.8 |
$15M |
|
12M |
1.24 |
Celldex Therapeutics Com New
(CLDX)
|
5.1 |
$11M |
|
323k |
34.06 |
Relmada Therapeutics
(RLMD)
|
4.3 |
$9.2M |
|
342k |
26.99 |
Iveric Bio
|
4.2 |
$9.1M |
|
540k |
16.83 |
Bcls Acquisition Corp- Cl A Com Cl A
|
3.9 |
$8.3M |
|
843k |
9.87 |
Gh Research Ordinary Shares
(GHRS)
|
3.6 |
$7.7M |
|
420k |
18.29 |
Kura Oncology
(KURA)
|
3.6 |
$7.6M |
|
474k |
16.08 |
Xenon Pharmaceuticals
(XENE)
|
3.2 |
$6.9M |
|
225k |
30.57 |
Miragen Therapeutics
(VRDN)
|
2.9 |
$6.3M |
|
340k |
18.49 |
Merus N V
(MRUS)
|
2.9 |
$6.2M |
|
236k |
26.44 |
Bellus Health Com New
|
2.6 |
$5.6M |
|
816k |
6.88 |
Jounce Therapeutics
|
2.6 |
$5.5M |
|
814k |
6.79 |
Jiya Acquisition Corp -cl A Com Cl A
|
2.6 |
$5.5M |
|
563k |
9.82 |
Pmv Pharmaceuticals Call Option
(PMVP)
|
2.3 |
$4.9M |
|
236k |
20.82 |
Fulcrum Therapeutics
(FULC)
|
2.2 |
$4.7M |
|
200k |
23.65 |
Mirati Therapeutics
|
2.0 |
$4.3M |
|
53k |
82.23 |
Avadel Pharmaceuticals Sponsored Adr
|
1.9 |
$4.0M |
|
580k |
6.83 |
Health Sciences Acquisitions Ord Shs
|
1.8 |
$3.9M |
|
393k |
9.91 |
Arrowhead Pharmaceuticals
(ARWR)
|
1.8 |
$3.8M |
|
83k |
45.99 |
Aclaris Therapeutics
(ACRS)
|
1.8 |
$3.8M |
|
218k |
17.24 |
Eyepoint Pharmaceuticals Com New
(EYPT)
|
1.7 |
$3.7M |
|
308k |
12.15 |
Syndax Pharmaceuticals
(SNDX)
|
1.7 |
$3.6M |
|
206k |
17.38 |
Horizon Therapeutics SHS
|
1.6 |
$3.5M |
|
33k |
105.21 |
Athira Pharma
(ATHA)
|
1.5 |
$3.2M |
|
240k |
13.50 |
Harpoon Therapeutics
|
1.2 |
$2.5M |
|
498k |
4.97 |
Milestone Pharmaceuticals
(MIST)
|
1.1 |
$2.4M |
|
380k |
6.42 |
Iovance Biotherapeutics
(IOVA)
|
0.9 |
$2.0M |
|
119k |
16.65 |
Verastem
|
0.7 |
$1.4M |
|
997k |
1.41 |
Molecular Templates
|
0.5 |
$1.1M |
|
307k |
3.45 |
Ventyx Biosciences
(VTYX)
|
0.4 |
$962k |
|
71k |
13.57 |
Pyxis Oncology Common Stock
(PYXS)
|
0.4 |
$808k |
|
200k |
4.04 |
Dice Therapeutics
|
0.3 |
$717k |
|
38k |
19.12 |
Call- Aciu 100@7 1/2exp 08/19/2022 SHS Call Option
(ACIU)
|
0.2 |
$400k |
|
100k |
4.00 |
ImmunoGen
|
0.1 |
$262k |
|
55k |
4.76 |
Apricus Biosciences
|
0.1 |
$248k |
|
296k |
0.84 |
Enanta Pharmaceuticals
(ENTA)
|
0.1 |
$164k |
|
2.3k |
71.30 |
Nuvation Warrants *w Exp 07/07/202
(NUVB)
|
0.0 |
$69k |
|
91k |
0.76 |